These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4469041)

  • 1. Study of the lipid-lowering action of choloxin and nilevar in patients with chronic renal failure.
    Wardle EN; Schardt W; Uldall PR; Brown A; Jonfiah D; Moore A; Park R; Wood E
    Postgrad Med J; 1974 Dec; 50(590):737-40. PubMed ID: 4469041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a hypocholesterolemic agent. Dextrothyroxine sodium (Choloxin).
    JAMA; 1969 May; 208(6):1014-5. PubMed ID: 5818672
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of nicotinic acid and miskleron on the lipid spectrum in chronic kidney failure].
    Pyrig LA; Petrun' NM; Mel'man NIa; Nikulina GG; Shinkarenko NR
    Urol Nefrol (Mosk); 1981; (3):42-5. PubMed ID: 7268975
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of norethandrolone (Nilevar) on serum proteins in the female guinea-pig.
    Reed M
    J Endocrinol; 1967 Mar; 37(3):253-60. PubMed ID: 6020254
    [No Abstract]   [Full Text] [Related]  

  • 5. Dextrothyroxine for lowering serum cholesterol. Analysis of data on 6066 patients.
    Bechtol LD; Warner WL
    Angiology; 1969 Nov; 20(10):565-79. PubMed ID: 5347944
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of anabolic steroids in chronic renal failure. I. Short-term effects.
    Sigler MH; Issekutz B
    Arch Intern Med; 1967 Oct; 120(4):408-16. PubMed ID: 6058096
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of dextrothyroxine on serum lipoprotein and cholesterol levels.
    Searcy RL; Hungerford DA; Low EM
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):177-86. PubMed ID: 4967872
    [No Abstract]   [Full Text] [Related]  

  • 8. A re-investigation of the effects of 'Nilevar' on the right gonad of the pullet.
    Wood HA; Gardner WA; Taber E
    Nature; 1966 Jul; 211(5048):536-7. PubMed ID: 6007772
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with dextrothyroxine in hypercholesterolemia.
    Owen WR
    Manit Med Rev; 1968 Oct; 48(8):370-3. PubMed ID: 5724154
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of an anabolic agent in psychiatry: Nilevar].
    Lebrun ; Capdevielle
    J Med Bord; 1965 Jun; 142(6):1114-9. PubMed ID: 5839539
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of dextro-thyroxine (choloxin) in cardiovascular disease. Report of a clinical study.
    Reinhardt DJ
    Del Med J; 1968 Mar; 40(3):63-7. PubMed ID: 4868744
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood lipid profile in hemodialysis patients treated with human erythropoietin.
    Mat O; Stolear JC; Georges B
    Nephron; 1992; 60(2):236-7. PubMed ID: 1553011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is hyperlipidemia a factor in the progression of renal failure?].
    Geiger H
    Z Kardiol; 1993; 82 Suppl 4():35-8. PubMed ID: 8147060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of nilevar (17-ethyl-19-nortestosterone) to suppress protein catabolism in acute renal failure.
    McCRACKEN BH; PARSONS FM
    Lancet; 1958 Oct; 2(7052):885-6. PubMed ID: 13589035
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipids and renal disease.
    Trevisan R; Dodesini AR; Lepore G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S145-7. PubMed ID: 16565240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid content of plasma in patients with chronic renal failure during hemodialysis treatment].
    Dembitskiĭ VM; Malyĭ VN
    Urol Nefrol (Mosk); 1984; (3):57-9. PubMed ID: 6740820
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipid disorders in chronic renal failure].
    Ducobu J; Dupont P; Hainaut J
    Rev Med Brux; 1983 Feb; 4(2):75-9. PubMed ID: 6342083
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholesterol lowering measures with clinical observations on a thyroid analogue (Sodium Dextrothyroxine) NaDT4; 91 cases--4 year study.
    Cooper EE; Michel AM
    Med Times; 1965 Oct; 93(10):1089-94. PubMed ID: 5826769
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum lipid in chronic renal failure.
    Das BS; Misra SK; Rao DV; Satpathy SR; Bose TK
    J Assoc Physicians India; 1984 Dec; 32(12):1019-21. PubMed ID: 6526792
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.